Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of the Hepatic Sinusoidal Obstruction Syndrome Secondary to Oxaliplatin-based Neoadjuvant Chemotherapy for Colorectal Liver Metastases by Means of Anticoagulants

NCT00885950 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT00885950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00885950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of the Hepatic Sinusoidal Obstruction Syndrome Secondary to Oxaliplatin-based Neoadjuvant Chemotherapy for Colorectal Liver Metastases by Means of Anticoagulants
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Completed
Start date
January 31, 2008
Completion date
June 30, 2010
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal liver metastases, sinusoidal obstruction syndrome